Joinn Laboratories(China)Co (603127) — Cash Flow-to-Debt Ratio
Joinn Laboratories(China)Co (603127) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥145.13 Million could theoretically repay 0% of its total liabilities (CN¥1.41 Billion) in one year. Check 603127 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Joinn Laboratories(China)Co Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Joinn Laboratories(China)Co across 14 annual periods. Also explore total assets of Joinn Laboratories(China)Co for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Joinn Laboratories(China)Co (2012–2025)
Year-by-year debt coverage analysis for Joinn Laboratories(China)Co. For market capitalisation and broader financial context, see market value of Joinn Laboratories(China)Co.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥444.57 Million | CN¥1.36 Billion | ▲ +27.3% |
| 2024 | 0.26x | CN¥338.93 Million | CN¥1.32 Billion | ▼ -30.6% |
| 2023 | 0.37x | CN¥647.73 Million | CN¥1.75 Billion | ▼ -17.0% |
| 2022 | 0.45x | CN¥971.07 Million | CN¥2.17 Billion | ▼ -9.2% |
| 2021 | 0.49x | CN¥685.66 Million | CN¥1.39 Billion | ▲ +1.6% |
| 2020 | 0.48x | CN¥428.39 Million | CN¥883.66 Million | ▲ +93.3% |
| 2019 | 0.25x | CN¥148.09 Million | CN¥590.57 Million | ▼ -30.2% |
| 2018 | 0.36x | CN¥176.08 Million | CN¥489.89 Million | ▲ +14.7% |
| 2017 | 0.31x | CN¥120.01 Million | CN¥383.08 Million | ▼ -11.2% |
| 2016 | 0.35x | CN¥118.82 Million | CN¥336.88 Million | ▼ -9.1% |
| 2015 | 0.39x | CN¥106.23 Million | CN¥273.64 Million | ▲ +37.9% |
| 2014 | 0.28x | CN¥82.38 Million | CN¥292.63 Million | ▲ +19.3% |
| 2013 | 0.24x | CN¥60.91 Million | CN¥258.21 Million | ▲ +225.8% |
| 2012 | 0.07x | CN¥20.33 Million | CN¥280.79 Million | — |